Page last updated: 2024-08-23

epirubicin and Basal Cell Cancer

epirubicin has been researched along with Basal Cell Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berry, FB; Buckley, NE; Crawford, NT; Gorski, JJ; Harkin, DP; Kennedy, RD; Mullan, PB; Tkocz, D	1

Other Studies

1 other study(ies) available for epirubicin and Basal Cell Cancer

Article	Year
BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers. Oncogene, 2012, Aug-09, Volume: 31, Issue:32 Topics: Antineoplastic Agents; Base Sequence; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; Epirubicin; Epithelial-Mesenchymal Transition; Female; Fluorouracil; Forkhead Transcription Factors; GATA3 Transcription Factor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Inhibitory Concentration 50; Mitomycin; Molecular Sequence Data; Neoplasms, Basal Cell; Phenotype; Promoter Regions, Genetic; Protein Binding; RNA Interference; Transcription, Genetic	2012

Article

Year

BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers.

Oncogene, 2012, Aug-09, Volume: 31, Issue:32

Topics: Antineoplastic Agents; Base Sequence; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; Epirubicin; Epithelial-Mesenchymal Transition; Female; Fluorouracil; Forkhead Transcription Factors; GATA3 Transcription Factor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Inhibitory Concentration 50; Mitomycin; Molecular Sequence Data; Neoplasms, Basal Cell; Phenotype; Promoter Regions, Genetic; Protein Binding; RNA Interference; Transcription, Genetic

2012